|
29.07.2013 22:01:00
|
National Instruments Reports Second Quarter Revenue of $296 Million
AUSTIN, Texas, July 29, 2013 /PRNewswire/ -- National Instruments (Nasdaq: NATI) today announced Q2 revenue of $296 million, a 1 percent increase from Q2 2012. In Q2, the company's orders under $20,000 declined 4 percent year-over-year; orders between $20,000 and $100,000 grew 4 percent year-over-year; and orders above $100,000 declined 30 percent year-over-year after growing approximately 130 percent year-over-year in Q2 2012.
GAAP net income for Q2 was $14 million, with fully diluted earnings per share (EPS) of $0.12, and non-GAAP net income was $22 million, with non-GAAP fully diluted EPS of $0.18. The company's GAAP EPS was $0.03 below the midpoint of its guidance range and non-GAAP EPS was $0.04 below the midpoint of its guidance range given on April 25, including a $0.01 per share loss on foreign exchange the company did not anticipate. EBITDA, or Earnings Before Interest, Taxes, Depreciation and Amortization, was $35million, or $0.28 per share for Q2.
In Q2, GAAP gross margin decreased to 72 percent and non-GAAP gross margin was 73 percent due to lower factory utilization and the significantly lower margin on National Instruments' first RF test application with its largest customer. This application is in a highly competitive space and in an area National Instruments has not served for this customer before. Total operating expenses were down $4 million sequentially and were up 4 percent year-over-year. Total non-GAAP operating expenses were down $5 million sequentially and were up 3 percent year-over-year.
The company's non-GAAP results exclude the impact of stock-based compensation, amortization of acquisition-related intangibles, acquisition accounting for deferred revenue, acquisition-related adjustments and acquisition-related transaction costs. Reconciliations of the company's GAAP and non-GAAP results are included as part of this news release.
National Instruments continued to deliver value to its largest customer and secured orders from this customer related to three different applications that use NI LabVIEW software and the NI PXI platform to rapidly develop a production test solution. In H1 2013, National Instruments received $30 million in orders from its largest customer, and recognized $23 million in revenue from this customer in Q2 2013.
"Although the test and measurement industry had a challenging quarter, we were able to grow revenue while executing disciplined cost management," said Dr. James Truchard, co-founder, president and CEO. "Thanks to the efforts of our employees, we have seen accelerated growth in customer leads and opportunities for our strategic product platforms oriented around LabVIEW despite the fact that customer budgets are tight."
Geographic revenue in U.S. dollar terms for Q2 2013 compared to Q2 2012 was down 1 percent in the Americas, up 2 percent in Europe, up 10 percent in East Asia and down 15 percent in Emerging Markets. In local currency terms, revenue was up 5percent in Europe, up 11 percent in East Asia and down 13 percent in Emerging Markets.
As of June 30, NI had $324 million in cash and short-term investments. The National Instruments Board of Directors approved a quarterly dividend of $0.14 per share on the company's common stock payable on Sept. 3, 2013 to stockholders of record on Aug. 12, 2013.
Guidance for Q3 2013
"Although Q2 was a difficult quarter for our industry and for National Instruments, we believe NI was able to gain market share," said Alex Davern, NI COO and CFO. "On the expense side, we delivered on reducing our spending and are adjusting our future spending plans to align with the industry's current weakness."
National Instruments continues to be conservative in planning for Q3 due to the weak industry conditions. As a result, NI expects revenue for Q3 2013 to be between $265 million and $295 million, a decrease of 3 percent year-over-year at the midpoint of guidance. For perspective, National Instruments recognized approximately $27 million in revenue from its largest customer in Q3 2012 and the company anticipates recognizing less than $5 million in revenue from this customer in Q3 2013. NI expects gross margins to increase approximately 250 to 300 basis points sequentially in Q3. NI expects total non-GAAP operating expenses to be $186 million, plus or minus $3 million in Q3. The company expects fully diluted EPS to be in the range of $0.04 to $0.16 for Q3, with non-GAAP fully diluted EPS expected to be in the range of $0.10 to $0.22.
Looking out to Q4, National Instruments is adjusting its spending plans to reflect the more difficult industry conditions. The company currently expects its total non-GAAP operating expenses will decline sequentially in Q4 and that non-GAAP operating expenses will be approximately $181million, plus or minus $3 million in Q4. National Instruments expects this to result in a significantly improved operating margin in Q4.
Non-GAAP Presentation
In addition to disclosing results determined in accordance with GAAP, NI discloses certain non-GAAP operating results and non-GAAP information that exclude certain charges. In this news release, the company has presented its gross profit, gross margin, operating expenses, operating income, operating margin, income before income taxes, provision for income taxes, net income and basic and fully diluted EPS for the three- and six-month periods ending June 30, 2013 and 2012, on a GAAP and non-GAAP basis. NI is also providing guidance on its non-GAAP operating expenses and fully diluted EPS.
When presenting non-GAAP information, the company includes a reconciliation of the non-GAAP results to the GAAP results. Management believes that including the non-GAAP results assists investors in assessing the company's operational performance and its performance relative to its competitors. The company presents these non-GAAP results as a complement to results provided in accordance with GAAP, and these results should not be regarded as a substitute for GAAP. Management uses these non-GAAP measures to manage and assess the profitability and performance of its business and does not consider stock-based compensation expense, amortization of acquisition-related intangibles, acquisition accounting for deferred revenue, acquisition-related adjustments and acquisition-related transaction costs in managing its operations. Specifically, management uses non-GAAP measures to plan and forecast future periods, to establish operational goals, to compare with its business plan and individual operating budgets, to measure management performance for the purposes of executive compensation including payments to be made under bonus plans, to assist the public in measuring the company's performance relative to the company's long-term public performance goals, to allocate resources and, relative to the company's historical financial performance, to enable comparability between periods. Management also considers such non-GAAP results to be an important supplemental measure of its performance.
This news release also discloses the company's EBITDA and EBITDA diluted EPS for the three- and six-month periods ending June 30, 2013 and 2012. The company also believes that including the EBITDA results assists investors in assessing the company's operational performance relative to its competitors. A reconciliation of EBITDA and EBITDA diluted EPS to GAAP net income and GAAP diluted EPS is included with this news release.
Conference Call Information and Availability of Presentation Materials
Interested parties can listen to the Q2 2013 conference call today, July 29, at 4:00 p.m. CT at ni.com/call. Replay information is available by calling (855) 859-2056, confirmation code #12343855, shortly after the call through Aug. 3 at 3:00 p.m. CT, or by visiting the company's website at ni.com/call. You may also view certain presentation materials that we may refer to on the conference call at ni.com/nati.
Forward-Looking Statements
This release contains "forward-looking statements," including continuing to focus on managing costs to improve operating margins, growth and customer leads and opportunities for our strategic product platforms while customer budgets are tight, gaining market share, adjusting future spending plans to align with industry weakness, being conservative in planning for Q3, anticipating recognizing less than $5 million in revenue from such customer in Q3 2013, National Instruments' Q3 guidance for revenue, gross margins, non-GAAP operating expenses and GAAP and non-GAAP EPS, adjusting spending plans to reflect the more difficult industry conditions, currently expecting total non-GAAP operating expenses will decline sequentially in Q4 and that non-GAAP operating expenses will be approximately $181 million, plus or minus $3 million in Q4 and expecting this to result in a significantly improved operating margin in Q4. These statements are subject to a number of risks and uncertainties, including the risk of adverse changes or fluctuations in the global economy, foreign exchange fluctuations, component shortages, delays in the release of new products, fluctuations in customer demand for NI products including orders from NI's largest customer, fluctuations in average order size and customer mix, the company's ability to effectively manage its operating expenses, manufacturing inefficiencies and the level of capacity utilization, adjustments to acquisition earn-out accruals and the impact of NI's recent and any future acquisitions. Actual results may differ materially from the expected results.
The company directs readers to its Form 10-K for the fiscal year ended Dec. 31, 2012, its Form 10-Q for the quarter ended March 31, 2013; and the other documents it files with the SEC for other risks associated with the company's future performance.
About National Instruments
Since 1976, National Instruments (www.ni.com) has equipped engineers and scientists with tools that accelerate productivity, innovation and discovery. NI's graphical system design approach to engineering provides an integrated software and hardware platform that speeds the development of any system needing measurement and control. The company's long-term vision and focus on improving society through its technology supports the success of its customers, employees, suppliers and shareholders. Readers can obtain investment information from the company's investor relations department by calling (512) 683-5090, emailing nati@ni.com or visiting www.ni.com/nati. (NATI-F)
LabVIEW, National Instruments, NI and ni.com are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.
Contact: Caitlin Gursslin, Investor Relations, caitlin.gursslin@ni.com
National Instruments | ||||
Consolidated Balance Sheets | ||||
(in thousands) | ||||
June 30, 2013 | Dec. 31, | |||
(unaudited) | 2012 | |||
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | $ | 169,580 | $ | 161,996 |
Short-term investments | 153,970 | 173,166 | ||
Accounts receivable, net | 172,880 | 187,060 | ||
Inventories, net | 185,278 | 169,990 | ||
Prepaid expenses and other current assets | 68,202 | 48,009 | ||
Deferred income taxes, net | 30,197 | 27,479 | ||
Total current assets | 780,107 | 767,700 | ||
Property and equipment, net | 263,915 | 249,721 | ||
Goodwill | 146,922 | 147,258 | ||
Intangible assets, net | 87,972 | 93,913 | ||
Other long-term assets | 25,303 | 26,177 | ||
Total assets | $ | 1,304,219 | $ | 1,284,769 |
Liabilities and Stockholders' Equity | ||||
Current liabilities: | ||||
Accounts payable | $ | 54,606 | $ | 65,080 |
Accrued compensation | 28,467 | 29,978 | ||
Deferred revenue – current | 95,137 | 90,714 | ||
Accrued expenses and other liabilities | 33,412 | 34,373 | ||
Other taxes payable | 22,315 | 24,811 | ||
Total current liabilities | 233,937 | 244,956 | ||
Deferred income taxes | 46,480 | 47,630 | ||
Liability for uncertain tax positions | 22,277 | 20,920 | ||
Deferred revenue – long-term | 21,120 | 20,446 | ||
Other long-term liabilities | 8,646 | 11,689 | ||
Total liabilities | 332,460 | 345,641 | ||
Stockholders' equity: | ||||
Preferred stock | - | - | ||
Common stock | 1,248 | 1,229 | ||
Additional paid-in capital | 568,426 | 532,845 | ||
Retained earnings | 402,597 | 404,210 | ||
Accumulated other comprehensive (loss) income | (512) | 844 | ||
Total stockholders' equity | 971,759 | 939,128 | ||
Total liabilities and stockholders' equity | $ | 1,304,219 | $ | 1,284,769 |
National Instruments | ||||||||||
Consolidated Statements of Income | ||||||||||
(in thousands, except per share data) | ||||||||||
Three Months Ended | Six Months Ended | |||||||||
June 30, | June 30, | |||||||||
(unaudited) | (unaudited) | |||||||||
2013 | 2012 | 2013 | 2012 | |||||||
Net sales: | ||||||||||
Product | $ | 275,663 | $ | 268,979 | $ | 541,081 | $ | 508,314 | ||
Software maintenance | 20,463 | 21,931 | 41,533 | 43,729 | ||||||
GSA accrual | - | 1,349 | - | 1,349 | ||||||
Total net sales | 296,126 | 292,259 | 582,614 | 553,392 | ||||||
Cost of sales: | ||||||||||
Product | 82,787 | 69,787 | 151,413 | 129,578 | ||||||
Software maintenance | 1,028 | 1,064 | 2,642 | 2,621 | ||||||
Total cost of sales | 83,815 | 70,851 | 154,055 | 132,199 | ||||||
Gross profit | 212,311 | 221,408 | 428,559 | 421,193 | ||||||
Operating expenses: | ||||||||||
Sales and marketing | 112,561 | 110,756 | 226,631 | 210,808 | ||||||
Research and development | 58,473 | 54,286 | 119,729 | 108,301 | ||||||
General and administrative | 22,156 | 21,502 | 45,000 | 42,876 | ||||||
Acquisition-related adjustment | - | - | (1,316) | - | ||||||
Total operating expenses | 193,190 | 186,544 | 390,044 | 361,985 | ||||||
Operating income | 19,121 | 34,864 | 38,515 | 59,208 | ||||||
Other income (expense): | ||||||||||
Interest income | 177 | 132 | 362 | 362 | ||||||
Net foreign exchange loss | (1,051) | (1,016) | (2,513) | (1,904) | ||||||
Other income, net | 400 | 151 | 424 | 255 | ||||||
Income before taxes | 18,647 | 34,131 | 36,788 | 57,921 | ||||||
Provision for income taxes | 4,226 | 7,690 | 3,767 | 12,838 | ||||||
Net income | $ | 14,421 | $ | 26,441 | $ | 33,021 | $ | 45,083 | ||
Basic earnings per share | $ | 0.12 | $ | 0.22 | $ | 0.27 | $ | 0.37 | ||
Diluted earnings per share | $ | 0.12 | $ | 0.22 | $ | 0.26 | $ | 0.37 | ||
Weighted average shares outstanding: | ||||||||||
Basic | 124,377 | 121,801 | 123,845 | 121,360 | ||||||
Diluted | 125,270 | 122,759 | 124,824 | 122,376 | ||||||
Dividends declared per share | $ | 0.14 | $ | $ 0.14 | $ | 0.28 | $ | 0.28 | ||
National Instruments | ||||
Consolidated Statements of Cash Flows | ||||
(in thousands) | ||||
Six Months Ended | ||||
June 30, | ||||
(unaudited) | ||||
2013 | 2012 | |||
Cash flow from operating activities: | ||||
Net income | $ | 33,021 | $ | 45,083 |
Adjustments to reconcile net income to net cash provided | ||||
by operating activities: | ||||
Depreciation and amortization | 33,555 | 27,316 | ||
Stock-based compensation | 14,006 | 13,285 | ||
Tax (expense) benefit from deferred income taxes | (3,633) | 6,695 | ||
Tax benefit from stock option plans | (2,042) | (2,094) | ||
Changes in operating assets and liabilities: | ||||
Accounts receivable | 14,358 | (31,203) | ||
Inventories | (14,732) | (16,994) | ||
Prepaid expenses and other assets | (18,418) | (17,625) | ||
Accounts payable | (10,612) | 10,596 | ||
Deferred revenue | 5,097 | 17,911 | ||
Taxes and other liabilities | (6,208) | (11,169) | ||
Net cash provided by operating activities | 44,392 | 41,801 | ||
Cash flow from investing activities: | ||||
Capital expenditures | (33,147) | (28,934) | ||
Capitalization of internally developed software | (8,073) | (9,664) | ||
Additions to other intangibles | (2,710) | (1,085) | ||
Purchases of short-term investments | (16,039) | (38,879) | ||
Sales and maturities of short-term investments | 35,234 | 183,058 | ||
Net cash (used in) provided by investing activities | (24,735) | 104,496 | ||
Cash flow from financing activities: | ||||
Proceeds from issuance of common stock | 20,612 | 14,422 | ||
Dividends paid | (34,727) | (34,019) | ||
Tax benefit from stock option plans | 2,042 | 2,094 | ||
Net cash used in financing activities | (12,073) | (17,503) | ||
Net change in cash and cash equivalents | 7,584 | 128,794 | ||
Cash and cash equivalents at beginning of period | 161,996 | 142,608 | ||
Cash and cash equivalents at end of period | $ | 169,580 | $ | 271,402 |
National Instruments | |||||||||
Detail of GAAP Charges Related to Revenue, Stock-Based Compensation, | |||||||||
Amortization of Acquisition Intangibles and Acquisition-Related Transaction Costs | |||||||||
(in thousands) | |||||||||
(unaudited) | |||||||||
Three Months Ended | Six Months Ended | ||||||||
June 30, | June 30, | ||||||||
2013 | 2012 | 2013 | 2012 | ||||||
Revenue | |||||||||
Acquisition-related deferred revenue | $ | - | $ | 887 | $ | - | $ | 2,156 | |
GSA accrual | - | (1,349) | - | (1,349) | |||||
Benefit from (provision for) income taxes | - | 162 | - | (282) | |||||
Total | $ | - | $ | (300) | $ | - | $ | 525 | |
Stock-based compensation | |||||||||
Cost of sales | $ | 408 | $ | 438 | $ | 829 | $ | 853 | |
Sales and marketing | 2,926 | 2,945 | 5,999 | 5,585 | |||||
Research and development | 2,596 | 2,679 | 5,333 | 5,128 | |||||
General and administrative | 942 | 921 | 1,845 | 1,720 | |||||
Provision for income taxes | (1,877) | (1,880) | (3,691) | (3,387) | |||||
Total | $ | 4,995 | $ | 5,103 | $ | 10,315 | $ | 9,899 | |
Amortization of acquisition intangibles | |||||||||
Cost of sales | $ | 2,613 | $ | 2,186 | $ | 5,373 | $ | 4,596 | |
Sales and marketing | 498 | 448 | 1,016 | 895 | |||||
Research and development | 569 | - | 1,242 | - | |||||
Other income, net | 188 | 193 | 381 | 382 | |||||
Provision for income taxes | (1,268) | (894) | (2,618) | (1,866) | |||||
Total | $ | 2,600 | $ | 1,933 | $ | 5,394 | $ | 4,007 | |
Acquisition-related transaction costs | |||||||||
Cost of sales | $ | 3 | $ | - | $ | 3 | $ | 32 | |
Sales and marketing | 142 | 19 | 260 | 239 | |||||
Research and development | 266 | 56 | 410 | 162 | |||||
General and administrative | 69 | 9 | 175 | 56 | |||||
Acquisition-related adjustment | - | - | (1,316) | - | |||||
Provision for income taxes | (153) | (29) | (259) | (171) | |||||
Total | $ | 327 | $ | 55 | $ | (727) | $ | 318 | |
National Instruments | ||||||||
Reconciliation of GAAP to Non-GAAP Measures | ||||||||
(in thousands, except per share data) | ||||||||
(unaudited) | ||||||||
Three Months Ended | Six Months Ended | |||||||
June 30, | June 30, | |||||||
2013 | 2012 | 2013 | 2012 | |||||
Reconciliation of Net Sales to Non-GAAP Net Sales | ||||||||
Net sales, as reported | $ | 296,126 | $ | 292,259 | $ | 582,614 | $ | 553,392 |
Acquisition-related deferred revenue | - | 887 | - | 2,156 | ||||
GSA accrual | - | (1,349) | - | (1,349) | ||||
Non-GAAP net sales | $ | 296,126 | $ | 291,797 | $ | 582,614 | $ | 554,199 |
Reconciliation of Gross Profit to Non-GAAP Gross Profit | ||||||||
Gross profit, as reported | $ | 212,311 | $ | 221,408 | $ | 428,559 | $ | 421,193 |
Acquisition-related deferred revenue and GSA accrual | - | (462) | - | 807 | ||||
Stock-based compensation | 408 | 438 | 829 | 853 | ||||
Amortization of acquisition intangibles | 2,613 | - | 5,373 | 32 | ||||
Acquisition-related transaction costs | 3 | 2,186 | 3 | 4,596 | ||||
Non-GAAP gross profit | $ | 215,335 | $ | 223,570 | $ | 434,764 | $ | 427,481 |
Non-GAAP gross margin | 73% | 77% | 75% | 77% | ||||
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses | ||||||||
Operating expenses, as reported | $ | 193,190 | $ | 186,544 | $ | 390,044 | $ | 361,985 |
Stock-based compensation | (6,464) | (6,545) | (13,177) | (12,433) | ||||
Amortization of acquisition intangibles | (1,067) | (448) | (2,258) | (895) | ||||
Acquisition-related adjustment | - | - | 1,316 | - | ||||
Acquisition-related transaction costs | (477) | (84) | (845) | (457) | ||||
Non-GAAP operating expenses | $ | 185,182 | $ | 179,467 | $ | 375,080 | $ | 348,200 |
Reconciliation of Operating Income to Non-GAAP Operating Income | ||||||||
Operating income, as reported | $ | 19,121 | $ | 34,864 | $ | 38,515 | $ | 59,208 |
Acquisition-related deferred revenue and GSA accrual | - | (462) | - | 807 | ||||
Stock-based compensation | 6,872 | 6,983 | 14,006 | 13,286 | ||||
Amortization of acquisition intangibles | 3,680 | 2,634 | 7,631 | 5,491 | ||||
Acquisition-related adjustment | - | - | (1,316) | - | ||||
Acquisition-related transaction costs | 480 | 84 | 848 | 489 | ||||
Non-GAAP operating income | $ | 30,153 | $ | 44,103 | $ | 59,684 | $ | 79,281 |
Non-GAAP operating margin | 10% | 15% | 10% | 14% | ||||
Reconciliation of Income Before Income Taxes to Non-GAAP Income Before Income Taxes | ||||||||
Income before income taxes, as reported | $ | 18,647 | $ | 34,131 | $ | 36,788 | $ | 57,921 |
Acquisition-related deferred revenue and GSA accrual | - | (462) | - | 807 | ||||
Stock-based compensation | 6,872 | 6,983 | 14,006 | 13,286 | ||||
Amortization of acquisition intangibles | 3,868 | 2,827 | 8,012 | 5,873 | ||||
Acquisition-related adjustment | - | - | (1,316) | - | ||||
Acquisition-related transaction costs | 480 | 84 | 848 | 489 | ||||
Non-GAAP income before income taxes | $ | 29,867 | $ | 43,563 | $ | 58,338 | $ | 78,376 |
Reconciliation of Provision for Income Taxes to Non-GAAP Provision for Income Taxes | ||||||||
Provision for income taxes, as reported | $ | 4,226 | $ | 7,690 | $ | 3,767 | $ | 12,838 |
Acquisition-related deferred revenue and GSA accrual | - | (162) | - | 282 | ||||
Stock-based compensation | 1,877 | 1,880 | 3,691 | 3,387 | ||||
Amortization of acquisition intangibles | 1,268 | 894 | 2,618 | 1,866 | ||||
Acquisition-related transaction costs | 153 | 29 | 259 | 171 | ||||
Non-GAAP provision for income taxes | $ | 7,524 | $ | 10,331 | $ | 10,335 | $ | 18,544 |
National Instruments | ||||||||
Reconciliation of GAAP Net Income, Basic EPS and Diluted EPS to Non-GAAP Net Income, Basic EPS and Diluted EPS | ||||||||
(in thousands, except per share data) | ||||||||
(unaudited) | ||||||||
Three Months Ended | Six Months Ended | |||||||
June 30, | June 30, | |||||||
2013 | 2012 | 2013 | 2012 | |||||
Net income, as reported | $ | 14,421 | $ | 26,441 | $ | 33,021 | $ | 45,083 |
Adjustments to reconcile net income to non-GAAP net income: | ||||||||
Acquisition-related deferred revenue, net of tax effect | - | (300) | - | 525 | ||||
Stock-based compensation, net of tax effect | 4,995 | 5,103 | 10,315 | 9,899 | ||||
Amortization of acquisition intangibles, net of tax effect | 2,600 | 1,933 | 5,394 | 4,007 | ||||
Acquisition-related adjustment | - | - | (1,316) | - | ||||
Acquisition-related transaction costs, net of tax effect | 327 | 55 | 589 | 318 | ||||
Non-GAAP net income | $ | 22,343 | $ | 33,232 | $ | 48,003 | $ | 59,832 |
Basic EPS, as reported | $ | 0.12 | $ | 0.22 | $ | 0.27 | $ | 0.37 |
Adjustment to reconcile basic EPS to non-GAAP basic EPS: | ||||||||
Impact of acquisition-related deferred revenue, net of tax effect | - | - | - | 0.01 | ||||
Impact of stock-based compensation, net of tax effect | 0.04 | 0.04 | 0.09 | 0.08 | ||||
Impact of amortization of acquisition intangibles, net of tax effect | 0.02 | 0.01 | 0.04 | 0.03 | ||||
Impact of acquisition-related adjustment | - | - | (0.01) | - | ||||
Impact of acquisition-related transaction costs, net of tax effect | - | - | - | - | ||||
Non-GAAP basic EPS | $ | 0.18 | $ | 0.27 | $ | 0.39 | $ | 0.49 |
Diluted EPS, as reported | $ | 0.12 | $ | 0.22 | $ | 0.26 | $ | 0.37 |
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS: | ||||||||
Impact of acquisition-related deferred revenue, net of tax effect | - | - | - | 0.01 | ||||
Impact of stock-based compensation, net of tax effect | 0.04 | 0.04 | 0.09 | 0.08 | ||||
Impact of amortization of acquisition intangibles, net of tax effect | 0.02 | 0.01 | 0.04 | 0.03 | ||||
Impact of acquisition-related adjustment | - | - | (0.01) | - | ||||
Impact of acquisition-related transaction costs, net of tax effect | - | - | - | - | ||||
Non-GAAP diluted EPS | $ | 0.18 | $ | 0.27 | $ | 0.38 | $ | 0.49 |
Weighted average shares outstanding: | ||||||||
Basic | 124,377 | 121,801 | 123,845 | 121,360 | ||||
Diluted | 125,270 | 122,759 | 124,824 | 122,376 | ||||
National Instruments | |||||||||||||
Reconciliation of Net Income and Diluted EPS to EBITDA and EBITDA Diluted EPS | |||||||||||||
(in thousands, except per share data) | |||||||||||||
(unaudited) | |||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||
June 30, | June 30, | ||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||
Net income, as reported | $ | 14,421 | $ | 26,441 | $ | 33,021 | $ | 45,083 | |||||
Adjustments to reconcile net income to EBITDA: | |||||||||||||
Interest income | (177) | (132) | (362) | (362) | |||||||||
Taxes | 4,226 | 7,690 | 3,767 | 12,838 | |||||||||
Depreciation and amortization | 16,726 | 13,201 | 33,555 | 27,316 | |||||||||
EBITDA | $ | 35,196 | $ | 47,200 | $ | 69,981 | $ | 84,875 | |||||
Diluted EPS, as reported | $ | 0.12 | $ | 0.22 | $ | 0.26 | $ | 0.37 | |||||
Adjustments to reconcile diluted EPS to EBITDA: | |||||||||||||
Interest income | - | - | - | - | |||||||||
Taxes | 0.03 | 0.06 | 0.03 | 0.10 | |||||||||
Depreciation and amortization | 0.13 | 0.10 | 0.27 | 0.22 | |||||||||
EBITDA diluted EPS | $ | 0.28 | $ | 0.38 | $ | 0.56 | $ | 0.69 | |||||
Weighted average shares outstanding – Diluted | 125,270 | 122,759 | 124,824 | 122,376 | |||||||||
National Instruments | |||||||||||||
Reconciliation of GAAP to Non-GAAP Operating Expense Guidance | |||||||||||||
(in millions) | |||||||||||||
(unaudited) | |||||||||||||
Three months ended | |||||||||||||
Sept. 30, 2013 | |||||||||||||
Low | High | ||||||||||||
GAAP operating expense, guidance | $ | 191 | $ | 197 | |||||||||
Adjustment to reconcile operating expense to non-GAAP | |||||||||||||
operating expense: | |||||||||||||
Impact of stock-based compensation | 7 | 7 | |||||||||||
Impact of amortization of acquisition intangibles | 1 | 1 | |||||||||||
Non-GAAP operating expense, guidance | $ | 183 | $ | 189 | |||||||||
Reconciliation of GAAP to Non-GAAP EPS Guidance | |||||||||||||
(unaudited) | |||||||||||||
Three months ended | |||||||||||||
Sept. 30, 2013 | |||||||||||||
Low | High | ||||||||||||
GAAP fully diluted EPS, guidance | $ | 0.04 | $ | 0.16 | |||||||||
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS: | |||||||||||||
Impact of stock-based compensation, net of tax effect | 0.04 | 0.04 | |||||||||||
Impact of amortization of acquisition intangibles, net of tax effect | 0.02 | 0.02 | |||||||||||
Non-GAAP diluted EPS, guidance | $ | 0.10 | $ | 0.22 | |||||||||
Reconciliation of GAAP to Non-GAAP EPS Guidance | |||||
(in millions) | |||||
(unaudited) | |||||
Three months ended | |||||
Dec. 31, 2013 | |||||
Low | High | ||||
GAAP operating expense, guidance | $ | 186 | $ | 192 | |
Adjustment to reconcile operating expense to non-GAAP | |||||
operating expense: | |||||
Impact of stock-based compensation | 7 | 7 | |||
Impact of amortization of acquisition intangibles | 1 | 1 | |||
Non-GAAP operating expense, guidance | $ | 178 | $ | 184 | |
SOURCE National Instruments
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu National Instruments Corp.mehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu National Instruments Corp.mehr Analysen
Letzte Top-Ranking Nachrichten
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.